W
WAVEMAN · COMPANY
ICFI · Icf International, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

ICFI

ICF International, Inc.
PHARMA & BIOTECH · SERVICES-MANAGEMENT CONSULTING SERVICES · CIK 0001362004
FORM 144 · 3☆ WATCH
INSIDER NET · 180D
-$1.2M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
0
13F, latest reported quarter
REVENUE GROWTH
-7.3%
XBRL, annual
NET MARGIN
4.9%
CONVERSIONS · 180D
16
codes C/M, not in net · $0 priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$1.2M over 180 days
-$1.7M over 90 days
below 63% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
fewer than five institutions report holding it
REVENUE
-7.3% year over year
below 68% of Pharma & Biotech
MARGIN
4.9% net margin
more than 74% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
3.4% of shares outstanding short · 3.0 days to cover · settled 2026-07-31
below 55% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
3 insiders have filed intent to sell ($1.7M) and have not sold yet.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -11.2%
-11.2%12M
-40%-26%-13%+1%2025-092025-102025-122026-032026-052026-072026-09 2026-07-13 · Wasson John sold $993.9K2026-09-01 · Wasson John sold $512.8K2026-05-15 · VAN HANDEL MICHAEL J bought $246.3K2026-05-15 · VAN HANDEL MICHAEL J bought $244.8K2025-10-02 · Morgan James C M sold $228.5K2026-08-26 · Ostria Sergio J sold $177.2K2026-03-06 · Mehl Randall bought $81.7K2026-09-01 · Wasson John sold $52.5K2025-11-17 · Mehl Randall bought $38.5K2025-11-14 · Mehl Randall bought $27.1K2025-11-14 · Mehl Randall bought $12.0K2025-09-25 · Morgan James C M sold $9.5K2026-09-01 · JOHN M WASSON REMAINDER TR 2022 filed to sell $570.2K2026-08-26 · SERGIO OSTRIA filed to sell $177.2K2026-07-13 · JOHN M WASSON REV TRUST U/A DTD 12/02/2020 filed to sell $953.5K
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $1.2M sold by insiders over 180 days, $1.7M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, ICF International, Inc. insiders sold a net $1.2M of stock across 70 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Wasson John
CEO & President
SELL
2026-09-01
585.0
$52.5K
Wasson John
CEO & President
SELL
2026-09-01
5,815.0
$512.8K
Ostria Sergio J
Executive Vice President
SELL
2026-08-26
2,000.0
$177.2K
Wasson John
CEO & President
SELL
2026-07-13
12,411.0
$993.9K
VAN HANDEL MICHAEL J
Director
BUY
2026-05-15
4,000.0
$246.3K
70 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 65 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported

no 13F holders found for this ticker

SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
JOHN M WASSON REMAINDER TR 2022
FILED 2026-09-01
$570.2K
SERGIO OSTRIA
FILED 2026-08-26
$177.2K
JOHN M WASSON REV TRUST U/A DTD 12/02/2020
FILED 2026-07-13
$953.5K
Executive pay vs shareholder return · John Wasson
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2023
$5.7M
$9.3M
$1.7M
+50%
+59%
2022
$4.8M
$4.6M
$1.5M
+10%
+35%
2021
$4.4M
$6.4M
$1.4M
+14%
+49%
2020
$3.0M
$2.7M
$2.3M
-18%
+18%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$1.9B$2.0B$2.0B$1.8B
OPERATING INCOME$145.5M$165.8M$132.3M$108.8M
NET INCOME$92.0M$110.0M$83.0M$64.0M
EPS (DILUTED)4.955.824.353.38
OPERATING CASH FLOW$141.9M$171.5M$152.4M$162.2M
CASH$5.3M$5.0M$6.4M$11.3M
LONG-TERM DEBT$401.4M$411.7M$404.4M$533.1M
DIVIDENDS PAID$10.4M$10.5M$10.5M$10.5M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →